Oscar B. Goodman

Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial

Christopher J. Logothetis, Ethan Basch, Arturo Molina et al. · The Lancet Oncology · 2012 · 280 citations

Medicine, Oncology, Pharmacology +17

Comparison of Circulating MicroRNA 141 to Circulating Tumor Cells, Lactate Dehydrogenase, and Prostate-Specific Antigen for Determining Treatment Response in Patients With Metastatic Prostate Cancer

Jason Cadaoas Gonzales, Louis M. Fink, Oscar B. Goodman et al. · Clinical Genitourinary Cancer · 2011 · 138 citations

Medicine, Oncology, Urology +17

Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial

Chung‐Han Lee, Robert J. Motzer, Hamid Emamekhoo et al. · Clinical Cancer Research · 2022 · 108 citations · Full text

Medicine, Oncology, Pharmacology +17

Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study

Fred Saad, Eleni Efstathiou, Gerhardt Attard et al. · The Lancet Oncology · 2021 · 106 citations · Full text

Medicine, Oncology, Urology +16

Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors

Oscar B. Goodman, Louis M. Fink, James T. Symanowski et al. · Cancer Epidemiology Biomarkers & Prevention · 2009 · 103 citations · Full text

Medicine, Oncology, Cancer Screening +16